Catalyst is a leading private equity firm in Israel with more than $250 million in assets under management. Since its founding in 1999, Catalyst has successfully completed over 25 investments and raised three funds.

Catalyst uses its knowledge, experience and resources to invest sensibly, create value for its portfolio companies and generate maximum returns for investors. We typically support capital and long-term growth of mature Israeli and Israeli-related innovative companies that have significant revenue, an impressive management team and a meaningful growth potential in global markets, with a special focus on China and other emerging markets. We at Catalyst see our platform as a highly effective conduit for Israeli innovative companies who are seeking global expansion, with a special emphasis on market entry into China backed by strong partners.

Catalyst leverages its unparalleled access to Israeli deal flow and global based network of partners, investors and strategic relationships across Israel, Europe, the US and China to create value for both our investors and our portfolio companies. Our managing partners enjoy a global and multidisciplinary background, wide-reaching operational, financial and sector expertise, significant business networks and vast transactional experience in global capital markets and cross-border M&A.

Catalyst’s current and past portfolio of companies include: Mobileye (NASDAQ, market cap $8.8B), Omrix Biopharmaceuticals (IPO on NASDAQ and then acquisition by Johnson & Johnson), Orex CR Technologies (acquired by Kodak), Lamina Technologies, Dori Media Group, Tufin and many others.

ib3 image
Catalyst-CEL Fund

Our latest private equity Fund was established in 2014 together with a strong financial partner in Hong Kong. The Fund supports the growth of mature Israeli companies and expansion into Greater China.

ib3 image
Catalyst Fund II L.P.

Catalyst’s second fund was established in 2006, moved away from VC investing and focused on private equity later-stage investment opportunities. Prominent exits: Mobileye’s IPO on Nasdaq. The Fund is still active until 2016.

ib3 image
Catalyst Fund L.P.

Established in 1999, Catalyst’s first fund was a venture capital fund that focused on maturing Israeli technology investments.





Catalyst primarily invests in mature public and private technology and industrial Israeli and Israeli-related companies that require a capital injection, strategic guidance and most importantly the right partner in order to expand their business in China and across the world. Our portfolio companies tend to be innovative, with significant revenues and already run profitable operations; they have significant growth potential and tangible growth engines, and lastly a highly capable and motivated management team.

We are long term investors and seek to partner with management to shape the future of their business. Our managing partners typically serve on the boards of our portfolio companies and are proactively involved. We work with our companies to best understand the operational and strategic challenges as well as the opportunities faced by them. This understanding enables our team to provide guidance and support that helps the companies realize their full potential. Our portfolio companies benefit from the vast transactional experience of our managing partners and their wide-reaching global networks.

Our sector diversification is key to Catalyst’s successful investment strategy. Our investments are spread over a wide variety of sectors, such as agriculture, energy, water, industrials & manufacturing processes, aerospace and defense, materials, chemicals, high-tech, med-tech, life sciences and others. We do not invest in financial or real-estate companies.



For additional information on Catalyst, please contact us :


28, Haarbaa St.
Tel Aviv, 64731, Israel


Catalyst CEL Fund

Catalyst CEL Fund
40/F,Far East Finance Centre,
16 Harcourt Road, Hong Kong